Skip to Main Content

Innovation and Diversity Summit Speakers

  • Gary H. Gibbons, M.D., is Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH), where he oversees the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees.
  • Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.
  • RADM Denise Hinton is FDA’s Chief Scientist.  In this capacity, she is responsible for leading and coordinating FDA's cross-cutting scientific and public health efforts.
  • CAPT Richardae Araojo serves as the Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA).  In this role, CAPT Araojo provides leadership, oversight, and direction on minority health and health disparity matters for the Agency. The Office of Minority Health and Health Equity aims to promote and protect the health of diverse populations through research and communication of regulatory science that addresses health disparities.
  • Dr. Lolic joined the FDA in 2008 as a clinical reviewer in the Office of New Drugs. She was involved in approvals of new drugs, improvement of post-marketing drug safety databases, and regulatory training for medical officers. Dr. Lolic is currently leading the Drug Trials Snapshot initiative. Her work focuses on demographics of clinical trial participants and variability in drug response among demographic subgroups.
  • Dr. Fabian Sandoval, CEO & Research Director, has over 20 years of bench to bedside research experience. His diversified research career has been in academia, healthcare systems and the public sector. He received his Bachelors of Science in molecular and cellular biology from Marymount University, and his Doctorate of Medicine from the Autonomous University of Guadalajara, School of Medicine.
  • YCCI recognizes that broadening community participation in clinical research involves linking investigators directly to resources in the community. To facilitate this, YCCI has partnered with Junta for Progressive Action and the African Methodist Episcopal Zion (AME Zion) Church to ensure that clinical trial participation reflects the diversity of New Haven’s population and will benefit patients in the community and beyond. Junta is the oldest Latino community based non-profit organization in New Haven and the AME Zion Church is New Haven’s oldest African American congregations.
  • Dr. Nancy J. Brown, recently appointed as the C.N.H. Long Professor of Internal Medicine, is an internationally renowned educator, investigator, and clinician. Her appointment will be effective Feb. 1, pending approval by the School of Medicine Board of Permanent Officers.
  • Dr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women’s Hospital, Boston Children’s Hospital, and Dana Farber Cancer Center. 

  • Dr. Krystal, who has been at Yale for ~40 years, is the ideal candidate to serve as the permanent co-PI, joining Dr. Smith to lead the Yale program. 

  • Allen Hsiao, MD, is Chief Medical Information Officer (CMIO), Yale New Haven Health and Yale School of Medicine. In this role, Allen leads a team of physician informaticians responsible for medical leadership of the electronic health record system (EHR) and supporting information technology systems to provide the functionality, clinical decision support, and innovation needed to deliver the best healthcare possible. Allen also oversees the DBAs, data architects, and the Joint Data Analytics Team (JDAT), a team of over 45 analysts that provide the reporting and analytics for the System and the School, supporting operational, clinical, and research reporting and data needs. Current priorities include strategies to address growing physician burnout, patient engagement, population health, and supporting genomic medicine.
  • Tesheia Johnson, MBA, MHS, is Deputy Director and Chief Operating Officer of YCCI and the Associate Director for Clinical Research for Yale School of Medicine, where she provides leadership and direction in the area of clinical research.